Literature DB >> 16043010

Video-thoracoscopic surgical pleurodesis in the management of malignant pleural effusion: the importance of an early intervention.

Antonio Marrazzo1, Antonio Noto, Luigi Casà, Pietra Taormina, Domenico Lo Gerfo, Massimo David, Sebastiano Mercadante.   

Abstract

Thoracentesis plays an important role in cancer patients with symptomatic effusions, although its effect is short-lived and symptoms recur in almost all patients. Early video-thoracoscopic surgical pleurodesis may provide added benefit to a group of patients with advanced cancer presenting with symptomatic malignant pleural effusion. Seventy-six patients with advanced cancer and pleural effusion due to pulmonary-pleural metastases were recruited. In 51 cases (67.1%), at least one thoracentesis was performed before admission for surgery. Preoperative staging consisted of chest radiograph, CT scan, and blood gas analysis. The mean Karnofsky performance status was about 50. Pleurodesis with talc poudrage was completely successful in all patients, with a morbidity rate of 2.6%. There was no post-operative mortality. Three patients (3.9%) underwent further thoracenteses for recurrence of pleural effusion within two months after the procedure. Early use of talc insufflated by video-thoracoscopic surgery is an effective and relatively safe method for treating pleural effusion, and preventing recurrence, in advanced cancer patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043010     DOI: 10.1016/j.jpainsymman.2005.01.015

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  7 in total

1.  Clinical-therapeutic management of thoracoscopy in pleural effusion: a groundbreaking technique in the twenty-first century.

Authors:  José Marcelo Galbis; Manuel Mata; Ricardo Guijarro; Rafael Esturi; Salvador Figueroa; Antonio Arnau
Journal:  Clin Transl Oncol       Date:  2011-01       Impact factor: 3.405

Review 2.  Interventional pulmonologist perspective: treatment of malignant pleural effusion.

Authors:  Andrew J Sweatt; Arthur Sung
Journal:  Curr Treat Options Oncol       Date:  2014-12

Review 3.  Management of malignant pleural effusion.

Authors:  Hongbin Chen; Julie Brahmer
Journal:  Curr Oncol Rep       Date:  2008-07       Impact factor: 5.075

Review 4.  Surgical and other invasive approaches to recurrent pleural effusion with malignant etiology.

Authors:  Siyamek Neragi-Miandoab
Journal:  Support Care Cancer       Date:  2008-02-08       Impact factor: 3.603

Review 5.  Diagnosis and management options in malignant pleural effusions.

Authors:  Ramakant Dixit; K C Agarwal; Archana Gokhroo; Chetan B Patil; Manoj Meena; Narender S Shah; Piyush Arora
Journal:  Lung India       Date:  2017 Mar-Apr

6.  Comparison of efficacy and toxicity between nedaplatin and cisplatin in treating malignant pleural effusion.

Authors:  Li-Zhe Zhong; Hong-Yan Xu; Zhong-Min Zhao; Guang-Mei Zhang; Feng-Wu Lin
Journal:  Onco Targets Ther       Date:  2018-09-05       Impact factor: 4.147

7.  Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion.

Authors:  Deirdre B Fitzgerald; Calvin Sidhu; Charley Budgeon; Ai Ling Tan; Catherine A Read; Benjamin C H Kwan; Nicola Ann Smith; Edward T Fysh; Sanjeevan Muruganandan; Tajalli Saghaie; Ranjan Shrestha; Arash Badiei; Phan Nguyen; Andrew Burke; John Goddard; Morgan Windsor; Julie McDonald; Gavin Wright; Kasia Czarnecka; Parthipan Sivakumar; Kazuhiro Yasufuku; David J Feller-Kopman; Nick A Maskell; Kevin Murray; Y C Gary Lee
Journal:  Trials       Date:  2022-06-27       Impact factor: 2.728

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.